#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Splenic marginal zone lymphoma IPEX syndrome Non-small cell lung cancer metastatic Myotonia Alexander disease Hereditary ataxia Hypoxic-ischaemic encephalopathy Malformation venous Pseudoxanthoma elasticum Porphyria non-acute Familial dilated cardiomyopathy Diffuse large B-cell lymphoma refractory Small cell lung cancer extensive stage Hypotransferrinaemia Dementia with Lewy bodies More trials…

    Learn about Rare Diseases

    Progressive supranuclear palsy – Basic Information Waldenstrom’s macroglobulinaemia refractory – Treatment Rhabdomyosarcoma – Diagnostics Toxic epidermal necrolysis – Trials in Disease Encephalitis autoimmune – Treatment Hereditary ataxia – Treatment Myelodysplastic syndrome – Trials in Disease Ewing’s sarcoma recurrent Angiosarcoma non-metastatic – Diagnostics Primary biliary cholangitis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSK5764227 Ranibizumab Glycopyrronium Bromide Blomia Tropicalis Autologous Pancreatic Islets Nofazinlimab Follitropin Beta Ofatumumab Sodium Iodide Tin816 ETX-19477 Metyrapone Bi 706321 Betula Verrucosa Pollen Cefaclor Fludarabine Phosphate L-SERINE Idelalisib Amlodipine Besilate ANUMIGILIMAB More therapies…

    Learn about Your Condition

    Micrographic skin surgery Oesophageal atresia Hepatic neoplasm Thymic carcinoma HER2 protein overexpression Epileptic encephalopathy Aphthous ulcer Coronary artery disease Raynaud's phenomenon Colitis Head injury Systemic sclerosis pulmonary Tonsillitis Autoimmune disorder Cryoglobulinaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hestia Duran I Reynals

Hestia Duran I Reynals

Avinguda de la Granvia de l'hospitalet 199-203, L'hospitalet De Llobregat, 08908, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • Study of precemtabart tocentecan alone or in drug combination versus standard therapy in previously treated metastatic colorectal cancer patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Bevacizumab
    • Tipiracil Hydrochloride
    • Trifluridine
    Austria Belgium Denmark France Germany Italy +3

  • A study to evaluate the effectiveness of tarlatamab in patients with extensive-stage small cell lung cancer that has progressed after prior treatment and who have limited health status

    Recruiting

    2 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Small cell lung cancer
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Tarlatamab
    France Greece Italy Spain

  • A Study of Atezolizumab and Bevacizumab Before and After Surgery in Patients with Liver Cancer at High Risk of Coming Back

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    Spain

  • Study on the Effectiveness and Safety of Pirtobrutinib and Rituximab for Untreated Adult Patients with Indolent Mantle Cell Lymphoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Pirtobrutinib
    • Rituximab
    Portugal Spain

  • Study on Cetuximab and Drug Combination for Patients with Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Bevacizumab
    • Calcium Levofolinate
    • Cetuximab
    Italy Spain

  • Study on Zanubrutinib and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Obinutuzumab
    • Zanubrutinib
    Spain

  • Study of Axitinib and Nivolumab for Patients with Metastatic Renal Cell Carcinoma Not Responding Completely to Initial Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastatic renal cell carcinoma
    Investigated Drugs:
    • Axitinib
    Italy Spain

  • Study on Pembrolizumab and Paclitaxel for Early Triple-Negative Breast Cancer in Patients with High Tumor-Infiltrating Lymphocytes

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Paclitaxel
    • Pembrolizumab
    France Spain

  • A study of cemiplimab in patients with locally advanced cutaneous squamous cell carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of skin
    Investigated Drugs:
    • Cemiplimab
    Spain

  • Pharmacokinetic, Safety, and Efficacy Evaluation of ASTX727 and Venetoclax in Adult Patients with Acute Myeloid Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cedazuridine
    • Decitabine
    • Venetoclax
    Spain
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!